Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
Renaissance Technologies
New York
| $469M | +$58.6M | 31 | 0.51% | Increased |
|
| 27 |
JP Morgan Chase
New York
| $448M | +$124M | 33 | 0.1% | Increased |
|
| 28 |
Janus Henderson Group
London,
| $412M | -$36.5M | 3 | 0.24% | Reduced |
|
| 29 |
Bank of New York Mellon
New York
| $386M | +$14.4M | 39 | 0.11% | Increased |
|
| 30 |
Invesco
Atlanta,
Georgia
| $377M | +$1.74M | 13 | 0.14% | Increased |
|
| 31 |
Geode Capital Management
Boston,
Massachusetts
| $343M | +$26.1M | 44 | 0.11% | Increased |
|
| 32 |
BBA
Baker Bros. Advisors
New York
| $343M | -$10.3M | 13 | 2.9% | Reduced |
|
| 33 |
RG
Redmile Group
San Francisco,
California
| $340M | +$50.9M | 5 | 13.11% | Increased |
|
| 34 |
Dimensional Fund Advisors
Austin,
Texas
| $335M | +$14.3M | 19 | 0.14% | Increased |
|
| 35 |
William Blair Investment Management
Chicago,
Illinois
| $327M | +$177M | 3 | 1.25% | Increased |
|
| 36 |
Thomaspartners
Boston,
Massachusetts
| $311M | +$9.38M | 1 | 2.28% | Increased |
|
| 37 |
NMC
NEA Management Company
Timonium,
Maryland
| $309M | +$22.3M | 2 | 13.75% | Increased |
|
| 38 |
Ameriprise
Minneapolis,
Minnesota
| $309M | +$94.6M | 17 | 0.14% | Increased |
|
| 39 |
Manning & Napier Group
Fairport,
New York
| $304M | -$14M | 1 | 2.98% | Reduced |
|
| 40 |
Norges Bank
Oslo,
Norway
| $296M | +$42.1M | 8 | 0.11% | Increased |
|
| 41 |
Millennium Management
New York
| $293M | +$91.9M | 36 | 0.39% | Increased |
|
| 42 |
EARNEST Partners
Atlanta,
Georgia
| $290M | +$326K | 4 | 2.75% | Increased |
|
| 43 |
Federated Hermes
Pittsburgh,
Pennsylvania
| $275M | +$32.4M | 20 | 0.8% | Increased |
|
| 44 |
Aristotle Capital Management
Los Angeles,
California
| $275M | +$17.4M | 1 | 1.85% | Increased |
|
| 45 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $272M | +$16.9M | 41 | 0.13% | Increased |
|
| 46 |
OrbiMed
New York
| $256M | +$70.9M | 10 | 3.18% | Increased |
|
| 47 |
First Trust Advisors
Wheaton,
Illinois
| $252M | +$86.5M | 7 | 0.58% | Increased |
|
| 48 |
Baupost Group
Boston,
Massachusetts
| $244M | +$32.6M | 1 | 2.35% | Increased |
|
| 49 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $235M | +$12.3M | 1 | 1.97% | Increased |
|
| 50 |
Lord, Abbett & Co
Jersey City,
New Jersey
| $224M | -$14.5M | 4 | 0.67% | Reduced |
|